The First Cancer Immunotherapy ETF
October 14, 2015 at 17:03 PM EDT
With the advancements in biotechnology generating some attractive investment opportunities, exchange traded fund investors may now focus on a group of companies that specialize in the growing field of cancer immunotheraphy. The Loncar Cancer Immunotheraphy ETF (NasdaqGM: CNCR) began trading...
